IJMS | Free Full-Text | Overview of Cellular Immunotherapies within Transfusion Medicine for the Treatment of Malignant Diseases
Mechanism of tumor regression caused by local IL-2 application of cancer | Download Scientific Diagram
Opdivo combined with novel IL-2 prodrug immune stimulant | Cancer Biology
Inspiring Target】IL-2: from signaling pathways to therapeutic potential in tumors and autoimmune diseases - ACROBiosystems
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus | PLOS Pathogens
Deciphering High-Dose IL-2 Toxicity in Reconstituted HIS Mice | genOway
RANKL Review
Interleukin 2 - Wikipedia
Effects of IL-2 combined with TGF-b blockade in PCa. Blockade of TGF-b... | Download Scientific Diagram
Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance | Journal for ImmunoTherapy of Cancer
Could a computer-designed IL-2 be a safer cancer treatment? | Fierce Biotech
Engineering IL-2 for immunotherapy of autoimmunity and cancer | Nature Reviews Immunology
An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism | Nature Communications
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone | NEJM
Frontiers | Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
Frontiers | Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity - ScienceDirect
High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute | Journal for ImmunoTherapy of Cancer | Full Text
JCI - PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
Application of IL-2 therapy to target T regulatory cell function: Trends in Immunology
IL-2 therapies
Cancer Immunotherapy with Interleukin-2— Current Status and Future Developments | touchONCOLOGY
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases | Nature Reviews Immunology
Interleukin-2–based therapies in cancer | Science Translational Medicine
In Vivo Expansion of Regulatory T Cells with IL-2/IL-2 Antibody Complex Protects against Transient Ischemic Stroke | Journal of Neuroscience
Implanted “Drug Factories” Deliver Immunotherapy to Tumors - NCI
![PDF] The coming of age of immuno-oncology : IL-2 therapy sets the stage | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/39d84d2d42367a89bb060bdad9001907a5f45d85/2-Figure1-1.png "PDF] The coming of age of immuno-oncology : IL-2 therapy sets the stage | Semantic Scholar")
PDF] The coming of age of immuno-oncology : IL-2 therapy sets the stage | Semantic Scholar
Healthcare | Free Full-Text | Scalp In-Transit Metastatic Melanoma Treated with Interleukin-2 and Pulsed Dye Laser
